Enovis Corp. Registered Shares o.N.
- BID
23.6
- ASK
23.8
- 320 Units314 Units
- 07/22, 07:25:27 AM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
5.36%
Market Cap
5.53 Bil.
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-18.37 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 23.6 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 09:55:57 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 23.6 | 23 |
| PREV. DAY'S PRICE | 23.4 | (07/20) |
| CHANGE DAY BEFORE | +0.20 | 0.85 % |
| 52 WEEK HIGH / LOW | 28.2 (10/27) | 17.4 (07/02) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.83 | -13.80 | -18.37 | 3.20 | 3.53 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | 8.07(e) | 7.42 | 6.72 |
PRICE - BOOK RATIO | 0.89 | 0.96 | 1.02 | - | - |
PRICE - SALES RATIO | 1.79 | 1.15 | 0.68 | - | - |
PRICE - CASH FLOW RATIO | 22.62 | 21.37 | 7.00 | - | - |
Master Data
| WKN | A3DHHV |
| ISIN | US1940145022 |
| SYMBOL | C520 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | ENOVIS CORP. |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | 5.53 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 9.26 % | 24.21 % | 16.83 % | 16.83 % | 5.36 % | -59.66 % | -64.27 % | 3.51 % |
| HIGH | 24.60 | 24.60 | 24.60 | 24.60 | 28.20 | 58.50 | 79.80 | 25.40 |
| LOW | 21.40 | 17.40 | 17.40 | 17.40 | 17.40 | 17.40 | 17.40 | 17.40 |
Dividende
pro Aktie
ENOVIS CORP. does not deliver dividend information
Company profile
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.